We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£490.00
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 3 months
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments for US Zip Codes
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 32 days · 32 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 32 days • 1 price levels
Price Analysis
Most common price: £490 (32 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 32 days
Description
This study covers the latent demand outlook for neuroendocrine tumor treatments across the states and zip codes of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 10,833 zip codes in the United States. For each zip code in question, the percent share the zip code is of its state and of the United States as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a zip code vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and zip code, latent demand estimates are created for neuroendocrine tumor treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of neuroendocrine tumor treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Advanced Accelerator Applications, Amgen, AVEO Oncology, Boehringer Ingelheim International, Bristol-Myers Squibb, Dauntless Pharmaceuticals, Eli Lilly, Exelixis, F. Hoffmann-La Roche, Hutchison MediPharma, Ipsen Pharma, Novartis, Pfizer, Progenics Pharmaceuticals, Sanofi, Tarveda Therapeutics, and Teva Pharmaceuticals Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
Product Specifications
- Format
- paperback
- ASIN
- B0BSW751P3
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 27 January 2023
Similar Products You Might Like
98% match
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China
£495.00
20 Aug 2026
98% match
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
£520.00
02 Sep 2026
98% match
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India
£515.00
02 Sep 2026
98% match
The 2025-2030 World Outlook for Neuroendocrine Tumor Treatments
Price unavailable
96% match
The 2023-2028 Outlook for Head and Neck Oncology Nutrition for US Zip Codes
£490.00
03 Sep 2026
96% match
Neuroendocrine Tumors: Surgical Evaluation and Management
Springer
£73.14
25 Sep 2026
95% match
The Spectrum of Neuroendocrine Neoplasia: A Practical Approach to Diagnosis, Classification and Therapy
Springer
£81.74
11 Sep 2026
95% match
The 2023-2028 Outlook for Head and Neck Oncology Nutrition in China
£495.00
26 Sep 2026
95% match
Neuroendocrine Tumours: Diagnosis and Management
Springer
£140.10
02 Oct 2026
95% match
Neuroendocrine Neoplasia Management: New Approaches for Diagnosis and Treatment
Springer
£96.81
24 Sep 2026
95% match
Neuroendocrine Tumors (Current Clinical Oncology)
Humana
£80.65
02 Oct 2026
95% match
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics for US Zip Codes
£490.00
11 Aug 2026
95% match
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments for US Zip Codes
£490.00
25 Aug 2026
95% match
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
£490.00
02 Oct 2026
95% match
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
£495.00
19 Aug 2026
95% match
The 2023-2028 Outlook for Natural Killer Cell Therapeutics for US Zip Codes
£490.00
21 Aug 2026
95% match
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
£325.00
27 Sep 2026
95% match
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments for US Zip Codes
£490.00
11 Aug 2026
95% match
Neuroendocrine Neoplasms, An Issue of PET Clinics: Volume 18-2 (The Clinics: Radiology, Volume 18-2)
Elsevier
£53.22
18 Sep 2026
95% match
Neuroendocrine Tumors Current Clinical Oncology Book
Humana
£107.85
07 Oct 2026
95% match
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics for US Zip Codes
£490.00
21 Aug 2026
95% match
The 2023-2028 Outlook for Non-Hodgkin Lymphoma for US Zip Codes
£490.00
28 Aug 2026
95% match
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
£325.00
26 Sep 2026
95% match
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments for US Zip Codes
£490.00
22 Aug 2026